Search for Clinical Trial Results
Glucagonoma - 50 Studies Found
Status | Study |
Terminated |
Study Name: Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer Condition:
|
Completed |
Study Name: Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu Condition:
|
Completed |
Study Name: Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma Condition:
|
Completed |
Study Name: Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer Condition:
|
Recruiting |
Study Name: Laser Tissue Welding - Distal Pancreatectomy Sealing Study Condition:
|
Not yet recruiting |
Study Name: Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor Condition:
|
Completed |
Study Name: PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors Condition:
Date: 2001-06-06 Interventions: Drug: bortezomib |
Terminated |
Study Name: Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy Condition: Pancreatic Cancer Date: 2010-01-25 Interventions:
|
Completed |
Study Name: Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors Condition:
Date: 2008-01-25 Interventions:
|
Completed |
Study Name: Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors Condition:
|